As medical device clinical trial as cylinder pump Anyfusion passed IRB (Institutional Review Board) with Pediatric Neonatology Department Professor Park, Min Soo at Yeonsei University Severance Hospical Medical Device Clinical Center under the title below, we would like to verify the technological and structural competitiveness of Cylinder pump to the conventional pump in terms of safety and efficacy in the absence of clinical validity for over 10 years as medicine infusion pump.

“A Prospective, Randomized, Open-label, Two-way Crossover, Single-institution Comparative Clinical Trial Evaluating the Safety and Efficacy of Cylinder Pump (ANyfusion® V-100) and Infusion Pump for Healthy Adult Volunteers”

After the first year clinical validation for the health adult, we would like to conduct clinical trials in the ICU, neonatal intensive care unit, and pediatric intensive care unit patients who need the highest safety and efficacy in the second year clinical trial and verify excellence of Anyfusion.

We aim to reach 80% market share in the drug injection pump market of $800 million.

Thank you.